Be a part of 3^rd International Conference on Oncology

We'll explore the dynamic interactions between tumor cells and their microenvironment, uncovering key insights into genetic and epigenetic alterations driving tumorigenesis. Additionally, we'll discuss the metabolic adaptations of cancer cells and their impact on tumor growth and survival.

• Track 2-1: Tumor Microenvironment
• Track 2-2: Tumor Heterogeneity
• Track 2-3: Epigenetics and Gene Regulation
• Track 2-4: Cancer Stem Cells
• Track 2-5: Tumor Angiogenesis and Vasculature
• Track 2-6: Biomarkers and Therapeutic Targets

We'll delve into the intricate mechanisms driving tumor development, proliferation, and metastasis, shedding light on the dynamic interplay between cancer cells and their surrounding microenvironment. Through insightful discussions, we'll explore the diverse pathways and genetic alterations underpinning different cancer types, offering valuable insights into disease progression and therapeutic resistance.

• Track 3-1: Oncogenesis and Tumor Initiation
• Track 3-2: Cancer Genomics and Transcriptomics
• Track 3-3: Tumor Progression and Metastasis

From traditional approaches like surgery and chemotherapy to cutting-edge innovations such as immunotherapy and targeted therapy, we'll delve into the nuances of each modality and discuss their respective strengths and limitations. Through engaging discussions, we'll highlight the importance of personalized treatment plans tailored to each patient's unique characteristics and tumor biology.

• Track 4-1: Surgical Innovations for Cancer Treatment
• Track 4-2: Chemotherapy
• Track 4-3: Radiation Therapy
• Track 4-4: Targeted Therapy
• Track 4-5: Immunotherapy
• Track 4-6: Hormonal Therapy

We’ll address the complexities of cancer care in older adults. We'll explore the unique considerations and obstacles faced in diagnosing, treating, and managing cancer in elderly patients, including issues related to comorbidities, functional status, and treatment tolerability.

• Track 5-1: Polypharmacy and Drug Interactions
• Track 5-2: Psychosocial and Supportive Care Needs
• Track 5-3: Treatment Tolerance and Toxicity

We'll unravel the enigmatic role of cancer stem cells in tumor heterogeneity, recurrence, and metastasis, shedding light on their unique properties and therapeutic implications. Through engaging discussions, we'll explore the dynamic interplay between cancer stem cells and the tumor microenvironment, uncovering novel strategies to target these elusive cells and disrupt tumor growth.

• Track 6-1: Cellular Heterogeneity and Plasticity
• Track 6-2: Tumor Microenvironment Interactions
• Track 6-3: Therapeutic Resistance and Relapse

From elucidating the molecular mechanisms of anticancer agents to exploring novel drug targets and treatment modalities, our discussions will encompass a diverse array of research endeavors. We'll also examine the translation of preclinical discoveries into clinical practice, evaluating the efficacy and safety of emerging therapies through rigorous clinical trials.

• Track 7-1: Drug Development and Discovery
• Track 7-2: Pharmacokinetics and Pharmacodynamics

We'll delve into the latest advancements in imaging modalities, such as MRI, CT, PET, and molecular imaging, and discuss their applications in early cancer detection, accurate staging, and treatment monitoring. Furthermore, we'll examine the development of novel biomarkers and imaging probes that offer insights into tumor biology and facilitate personalized treatment strategies.

• Track 8-1: Radiological Imaging Modalities
• Track 8-2: Molecular Imaging
• Track 8-3: Functional Imaging Techniques
• Track 8-4: Image-Guided Biopsy
• Track 8-5: Artificial Intelligence (AI) in Imaging

This session will illuminate the transformative potential of genomic technologies in shaping the future of cancer diagnosis and treatment. From elucidating the role of genetic mutations in cancer development to exploring personalized treatment strategies tailored to individual patients, our discussions will encompass cutting-edge research and innovative approaches.

• Track 9-1: Genomic Profiling Technologies
• Track 9-2: Biomarker Discovery and Validation
• Track 9-3: Biomarker Discovery and Validation
• Track 9-4: Hereditary Cancer Syndromes

Our esteemed speakers will delve into topics such as lifestyle modifications, vaccination initiatives, and environmental risk reduction measures aimed at lowering the incidence of cancer. Through engaging presentations and interactive discussions, attendees will have the opportunity to gain valuable knowledge, exchange ideas, and explore innovative approaches to cancer prevention.

• Track 10-1: Screening and Early Detection
• Track 10-2: Genetic Counseling and Testing
• Track 10-3: Chemoprevention

This session will highlight the critical role of patient empowerment and advocacy in cancer care. Through informative presentations and interactive discussions, attendees will gain insights into the importance of educating patients about their diagnosis, treatment options, and supportive care resources. Additionally, we will explore the pivotal role of advocacy organizations and support networks in championing the needs of cancer patients and survivors.

• Track 11-1: Cultural Competence and Diversity
• Track 11-2: Technology and Digital Health Solutions
• Track 11-3: Financial Support and Resource Navigation

This session will provide a comprehensive exploration of the latest advancements and breakthroughs in cancer research methodologies and clinical trial practices. Attendees will have the opportunity to engage with leading experts in the field, learn about innovative studies and therapeutic approaches, and discuss the implications of research findings on clinical practice.

We welcome submissions focusing on various aspects of survivorship, including long-term effects of cancer treatment, psychosocial support, survivorship care planning, and strategies for enhancing quality of life post-treatment. Additionally, we encourage abstracts addressing rehabilitation interventions aimed at improving physical, emotional, and cognitive function in cancer survivors.

• Track 13-1: Survivorship Care Planning
• Track 13-2: Quality of Life and Psychosocial Support
• Track 13-3: Cognitive Rehabilitation and Neurocognitive Support
• Track 13-4: Vocational Rehabilitation
• Track 13-5: Nutritional Support and Dietary Counseling

We welcome abstracts covering a wide range of topics, including nanoparticle-based drug delivery systems, nano-scale imaging technologies, and nanomaterials for targeted therapy and immunotherapy.

• Track 14-1: Targeted Nanomedicines
• Track 14-2: Theranostic Nanoparticles
• Track 14-3: Nanotoxicology and Safety Assessment
• Track 14-4: Tumor-targeting Nanodevices

We welcome abstracts covering a wide range of topics, including tobacco control, cancer screening programs, healthcare policies, health disparities, and implementation science. Join us in exploring the intersection of public health and policy in the fight against cancer and shaping the future of cancer care. Submit your abstracts today and contribute to advancing knowledge, fostering collaboration, and driving positive change in cancer prevention and control.

• Track 15-1: Cancer Prevention Policies
• Track 15-2: Palliative and Supportive Care Policies
• Track 15-3: Survivorship Care Policies
• Track 15-4: Health Communication and Education Initiatives

This session will provide a unique opportunity for clinicians, researchers, and healthcare professionals to share their impactful case studies and innovative clinical research findings in the field of oncology. We welcome abstracts covering a broad spectrum of topics, including challenging patient cases, novel treatment approaches, therapeutic outcomes, and lessons learned from clinical practice.

• Track 16-1: Treatment Strategies and Outcomes
• Track 16-2: Complications and Adverse Events
• Track 16-3: Novel Therapeutic Approaches
• Track 16-4: Multicenter Collaborative Studies
• Track 16-5: Lessons Learned and Best Practices